High mRNA expression of GCLC in tumor tissue significantly shortens the postoperative recurrence survival period of patients, and potentially can predict cisplatin resistance in patients with lung adenocarcinoma (Hiyama et al., 2018). This evidence concerns the gene GCLC and lung adenocarcinoma.